Merakris Therapeutics, Inc. is a biotechnology company based in Research Triangle Park, North Carolina, founded in 2016. The company's slogan emphasizes its leadership in developing regenerative products within the aesthetic, wound care, and ophthalmology markets. They are focused on researching, developing, and marketing regenerative healthcare products, using commercially scalable biotherapeutic technologies derived from stem cells to promote homeostasis in damaged tissue.
Merakris Therapeutics aims to be a leader in the research and development of regenerative medicine, delivering effective medical therapies that require fewer treatments and improve patient outcomes, while reducing the overall cost of care. They also prioritize educating patients and healthcare providers about the benefits of alternative therapies and regenerative medicine in comparison to standard or more invasive treatment options.
With a focus on biotechnology and healthcare, Merakris Therapeutics is positioned to make a significant impact in the health and wellness industry. However, there is no information available regarding their headquarters or last investment at this time.
There is no investment information
No recent news or press coverage available for Merakris Therapeutics, Inc..